4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001104659-26-086733
Director gave up 60 shares (to pay taxes)
- Director acquired 195,211 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Redmile Group, LLC · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-22 | Exercise or conversion : show line 1 in the form | +195,211 | 636,912 | I |
| 2026-07-22 | Shares withheld for taxes : show line 2 in the form | −60 | 636,852 | I |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-22 | Exercise or conversion : show line 3 in the form Pre-Funded Warrants to Purchase Common Stock | −101,089 | 0 | I |
| 2026-07-22 | Exercise or conversion : show line 4 in the form Pre-Funded Warrants to Purchase Common Stock | −38,735 | 0 | I |
| 2026-07-22 | Exercise or conversion : show line 5 in the form Pre-Funded Warrants to Purchase Common Stock | −55,387 | 0 | I |
Loading xslF345X06/tm2621190-2_4seq1.xml…